William Blair Issues Optimistic Estimate for LENZ Earnings
LENZ Therapeutics, Inc. (NASDAQ:LENZ – Free Report) – Investment analysts at William Blair increased their Q2 2025 earnings estimates for shares of LENZ Therapeutics in a research note issued to investors on Thursday, May 8th. William Blair analyst L. Hanbury-Brown now anticipates that the company will post earnings per share of ($0.66) for the quarter, […]
LENZ Therapeutics, Inc. (NASDAQ:LENZ – Free Report) – Investment analysts at William Blair increased their Q2 2025 earnings estimates for shares of LENZ Therapeutics in a research note issued to investors on Thursday, May 8th. William Blair analyst L. Hanbury-Brown now anticipates that the company will post earnings per share of ($0.66) for the quarter, […]
